Massive Hepatocellular Carcinoma with Situs Inversus Totalis Achieved a Complete Response Following Camrelizumab Plus Apatinib and Combined with Two-Stage Hepatectomy: A Case Report

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.21590
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.21338
   PubMed Web of Science ®Google Scholar
• Petrick JL, Florio AA, Znaor A, et al. International trends in hepatocellular carcinoma incidence, 1978–2012. Int J Cancer. 2020;147(2):317–330.
   PubMed Web of Science ®Google Scholar
• Zheng R, Zhang S, Zeng H, et al. Cancer incidence and mortality in China, 2016. J Natl Cancer Center. 2022;2(1):1–9.
   Google Scholar
• Yuan JM, Govindarajan S, Henderson BE, Yu MC. Low prevalence of hepatitis C infection in hepatocellular carcinoma (HCC) cases and population controls in Guangxi, a hyperendemic region for HCC in the People’s Republic of China. Br J Cancer. 1996;74(3):491–493.
   PubMed Web of Science ®Google Scholar
• Wang XY, Huang JM, Lu XM, et al. Changing risk factors for hepatocellular carcinoma in hyperendemic regions in the era of universal hepatitis B vaccination. Cancer Epidemiol. 2020;67:101775.
   PubMed Web of Science ®Google Scholar
• Lin MV, King LY, Chung RT. Hepatitis C virus-associated cancer. Annu Rev Pathol. 2015;10:345–370.
   PubMed Web of Science ®Google Scholar
• Yamashita T, Honda M, Kaneko S. Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection. J Gastroenterol Hepatol. 2011;26(6):960–964.
   PubMed Web of Science ®Google Scholar
• Bartosch B, Thimme R, Blum HE, Zoulim F. Hepatitis C virus-induced hepatocarcinogenesis. J Hepatol. 2009;51(4):810–820. doi:10.1016/j.jhep.2009.05.008
   PubMed Web of Science ®Google Scholar
• Jeong SW, Jang JY, Chung RT. Hepatitis C virus and hepatocarcinogenesis. Clin Mol Hepatol. 2012;18(4):347–356. doi:10.3350/cmh.2012.18.4.347
   PubMedGoogle Scholar
• Liu W, Guo TF, Jing ZT, et al. Hepatitis B virus core protein promotes hepatocarcinogenesis by enhancing Src expression and activating the Src/PI3K/Akt pathway. FASEB J. 2018;32(6):3033–3046. doi:10.1096/fj.201701144R
   PubMed Web of Science ®Google Scholar
• Tsuge M. The association between hepatocarcinogenesis and intracellular alterations due to hepatitis B virus infection. Liver Int. 2021;41(12):2836–2848. doi:10.1111/liv.15065
   PubMed Web of Science ®Google Scholar
• Lefeuvre C, Le Guillou-Guillemette H, Ducancelle A, Pleiotropic A. Role of the hepatitis B virus core protein in hepatocarcinogenesis. Int J Mol Sci. 2021;22:24. doi:10.3390/ijms222413651
   Web of Science ®Google Scholar
• Han C, Yu T, Qin W, et al. Genome-wide association study of the TP53 R249S mutation in hepatocellular carcinoma with aflatoxin B1 exposure and infection with hepatitis B virus. J Gastrointest Oncol. 2020;11(6):1333–1349. doi:10.21037/jgo-20-510
   PubMed Web of Science ®Google Scholar
• Zhu Q, Ma Y, Liang J, et al. AHR mediates the aflatoxin B1 toxicity associated with hepatocellular carcinoma. Signal Transduct Target Ther. 2021;6(1):299. doi:10.1038/s41392-021-00713-1
   PubMed Web of Science ®Google Scholar
• Zhou R, Liu M, Liang X, Su M, Li R. Clinical features of aflatoxin B1-exposed patients with liver cancer and the molecular mechanism of aflatoxin B1 on liver cancer cells. Environ Toxicol Pharmacol. 2019;71:103225. doi:10.1016/j.etap.2019.103225
   PubMed Web of Science ®Google Scholar
• Long XD, Ma Y, Zhou YF, Ma AM, Fu GH. Polymorphism in xeroderma pigmentosum complementation group C codon 939 and aflatoxin B1-related hepatocellular carcinoma in the Guangxi population. Hepatology. 2010;52(4):1301–1309. doi:10.1002/hep.23807
   PubMed Web of Science ®Google Scholar
• Su H, Han C, He Y, et al. Molecular mechanism of CK19 involved in the regulation of postoperative recurrence of HBV-associated primary hepatocellular carcinoma in Guangxi. Ann Transl Med. 2021;9(24):1780. doi:10.21037/atm-21-6020
   PubMed Web of Science ®Google Scholar
• Thomas MB, Zhu AX. Hepatocellular carcinoma: the need for progress. J Clin Oncol. 2005;23(13):2892–2899. doi:10.1200/JCO.2005.03.196
   PubMed Web of Science ®Google Scholar
• Graf D, Vallbohmer D, Knoefel WT, et al. Multimodal treatment of hepatocellular carcinoma. Eur J Intern Med. 2014;25(5):430–437. doi:10.1016/j.ejim.2014.03.001
   PubMed Web of Science ®Google Scholar
• Zhou J, Sun H, Wang Z, et al. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 edition). Liver Cancer. 2020;9(6):682–720. doi:10.1159/000509424
   PubMed Web of Science ®Google Scholar
• Zhuo W, Li A, Yang W, Duan J, Min J, Wei J. Case report: hepatic artery infusion chemotherapy after stage I ALPPS in a patient with huge HCC. Front Surg. 2021;8:746618. doi:10.3389/fsurg.2021.746618
   PubMed Web of Science ®Google Scholar
• Au KP, Chan ACY. Current status of associating liver partition with portal vein ligation for staged hepatectomy: comparison with two-stage hepatectomy and strategies for better outcomes. World J Gastroenterol. 2019;25(43):6373–6385. doi:10.3748/wjg.v25.i43.6373
   PubMed Web of Science ®Google Scholar
• Clavien P-A, Petrowsky H, Michelle L, Graf R. Strategies for safer liver surgery and partial liver transplantation. N England J Med. 2007;356(15):1545–1559. doi:10.1056/NEJMra065156
   PubMed Web of Science ®Google Scholar
• Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg. 2000;232(6):777–785. doi:10.1097/00000658-200012000-00006
   PubMed Web of Science ®Google Scholar
• Zhao HT, Cai JQ. Chinese expert consensus on neoadjuvant and conversion therapies for hepatocellular carcinoma. World J Gastroenterol. 2021;27(47):8069–8080. doi:10.3748/wjg.v27.i47.8069
   PubMed Web of Science ®Google Scholar
• Sun HC, Zhou J, Wang Z, et al. Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition). Hepatobiliary Surg Nutr. 2022;11(2):227–252. doi:10.21037/hbsn-21-328
   PubMed Web of Science ®Google Scholar
• Xu J, Shen J, Gu S, et al. Camrelizumab in combination with apatinib in patients with advanced hepatocellular carcinoma (RESCUE): a nonrandomized, open-label, phase II trial. Clin Cancer Res. 2021;27(4):1003–1011. doi:10.1158/1078-0432.CCR-20-2571
   PubMed Web of Science ®Google Scholar
• Mei K, Qin S, Chen Z, Liu Y, Wang L, Zou J. Camrelizumab in combination with apatinib in second-line or above therapy for advanced primary liver cancer: cohort A report in a multicenter phase Ib/II trial. J Immunother Cancer. 2021;9:3. doi:10.1136/jitc-2020-002191
   Web of Science ®Google Scholar
• Xu Q, Liu W, Lin C, Dang Y, Lin C. Transverse colon cancer with obstruction in a patient with situs inversus totalis: a case report and review of literature. Asian J Surg. 2020;43(12):1186–1188. doi:10.1016/j.asjsur.2020.09.003
   PubMed Web of Science ®Google Scholar
• Patel RB, Gupta NR, Vasava NC, Khambholja JR, Chauhan S, Desai A. Situs Inversus Totalis (SIT) with Hepatocellular Carcinoma (HCC): a rare case report and review of 12 other cases. Indian J Surg. 2013;75(6):424–429. doi:10.1007/s12262-012-0744-9
   PubMed Web of Science ®Google Scholar
• Schima W, Heiken J. LI-RADS v2017 for liver nodules: how we read and report. Cancer Imaging. 2018;18(1):14. doi:10.1186/s40644-018-0149-5
   PubMedGoogle Scholar
• Maupoey Ibanez J, Montalva Oron EM, Bosca Robledo A, et al. From conventional two-stage hepatectomy to ALPPS: fifteen years of experience in a hepatobiliary surgery unit. Hepatobiliary Pancreat Dis Int. 2021;20(6):542–550. doi:10.1016/j.hbpd.2021.08.001
   PubMed Web of Science ®Google Scholar
• Deng Z, Jin Z, Qin Y, et al. Efficacy of the association liver partition and portal vein ligation for staged hepatectomy for the treatment of solitary huge hepatocellular carcinoma: a retrospective single-center study. World J Surg Oncol. 2021;19(1):95. doi:10.1186/s12957-021-02199-1
   PubMed Web of Science ®Google Scholar
• Zeng H, Zheng R, Guo Y, et al. Cancer survival in China, 2003–2005: a population-based study. Int J Cancer. 2015;136(8):1921–1930. doi:10.1002/ijc.29227
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. Electronic address: eee, European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236.
   PubMed Web of Science ®Google Scholar
• Xie DY, Ren ZG, Zhou J, Fan J, Gao Q. 2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights. Hepatobiliary Surg Nutr. 2020;9(4):452–463.
   PubMed Web of Science ®Google Scholar
• Wang K, Guo WX, Chen MS, et al. Multimodality treatment for hepatocellular carcinoma with portal vein tumor thrombus: a large-scale, multicenter, propensity mathching score analysis. Medicine. 2016;95(11):e3015.
   PubMed Web of Science ®Google Scholar
• Niki Y, Shiraki K, Enokimura N, et al. Hepatocellular carcinoma associated with situs inversus totalis. J Clin Gastroenterol. 2004;38(4):382–383.
   PubMed Web of Science ®Google Scholar
• Kakinuma D, Tajiri T, Yoshida H, et al. A case of hepatocellular carcinoma with situs inversus totalis. J Nippon Med Sch. 2004;71(3):209–212.
   PubMedGoogle Scholar
• Li T, Wang L, Chen RX, et al. Hepatocellular carcinoma with situs inversus totalis and polysplenia syndrome. Liver Int. 2007;27(10):1430–1431.
   PubMed Web of Science ®Google Scholar
• Fu RD, Li JY, Zhang XH, Chen HW. Right hemihepatectomy via an anterior approach for hepatocellular carcinoma in a situs inversus totalis patient. Case Rep Gastroenterol. 2020;14(1):91–97.
   PubMedGoogle Scholar
• Liao KX, Li JW, Author Reflections ASO, New Minimally A. Invasive procedure for hepatocellular carcinoma with situs inversus totalis. Ann Surg Oncol. 2021;28(11):6832–6833.
   PubMed Web of Science ®Google Scholar
• Liao KX, Cao L, Zheng SG, Li JW. Pure laparoscopic anatomic right hemihepatectomy for hepatocellular carcinoma with situs inversus totalis using indocyanine green fluorescence staining (with video). Ann Surg Oncol. 2021;28(11):6830–6831.
   PubMed Web of Science ®Google Scholar
• Harada K, Masuda T, Beppu T, et al. Hepatic resection using a liver-hanging maneuver and Glissonean pedicle transection for hepatocellular carcinoma in a patient with situs inversus totalis: report of a case. Surg Today. 2012;42(8):801–804.
   PubMed Web of Science ®Google Scholar
• Xu JB, Xu G, Chen GF, Gu DH, Zhang JH, Qi FZ. Hepatocellular carcinoma with hypersplenic thrombocytopenia and situs inversus totalis: a case report. Chin Med Sci J. 2016;31(2):134–136.
   PubMedGoogle Scholar
• Kamiike W, Itakura T, Tanaka H, et al. Hepatic segmentectomy on primary liver cancer with situs inversus totalis. HPB Surg. 1996;9(3):169–172.
   PubMedGoogle Scholar